MOSAIC

Middle-Infrared Optical Spectroscopy for Anaesthetic Agent and Carbon Isotope Analysis

 Coordinatore MITTATEKNIIKAN KESKUS 

 Organization address address: Tekniikantie 1
city: ESPOO
postcode: 2150

contact info
Titolo: Dr.
Nome: Antti
Cognome: Lassila
Email: send email
Telefono: +358 10 6054413
Fax: +358 10 6054299

 Nazionalità Coordinatore Finland [FI]
 Totale costo 45˙000 €
 EC contributo 45˙000 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2010-RG
 Funding Scheme MC-ERG
 Anno di inizio 2011
 Periodo (anno-mese-giorno) 2011-03-01   -   2014-02-28

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    MITTATEKNIIKAN KESKUS

 Organization address address: Tekniikantie 1
city: ESPOO
postcode: 2150

contact info
Titolo: Dr.
Nome: Antti
Cognome: Lassila
Email: send email
Telefono: +358 10 6054413
Fax: +358 10 6054299

FI (ESPOO) coordinator 45˙000.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

ccs    spectral    exhaled    levels    plasma    drugs    ratio    middle    million    modern    cross    emissions    monitoring    anaesthesia    crds    breath    co    leakages    storage    isotope    mid    first    spectroscopy    infrared    detect    ring    anaesthetic    carbon    blood    propofol    optical    instruments    micrometre    surgery    intravenously    construction    administered    gas    inhaled    wavelength    fossil    ultra    capture    monitor    designed    clinical    samples    disciplinary    cavity    mosaic    people    sensitive    ir    performed    undergo   

 Obiettivo del progetto (Objective)

'The proposed cross-disciplinary project takes ultra-sensitive optical cavity ring-down spectroscopy (CRDS) beyond the state of the art by allowing practical CRDS instruments in the mid-IR spectral range where many analytically interesting gas molecules have strongest absorption. Such a step change in CRDS technology is enabled by the recent advances of the quantum cascade lasers. The cutting edge sensor technology will be used to address two topical and high impact cross-disciplinary measurement challenges. The first challenge is in the field of medical exhaled breath analytics and the second one in the measurement of carbon isotope 14-C/12-C ratio.

Every year over 100 million people undergo surgery, mostly performed under general anaesthesia. The majority of operations are performed using inhaled anaesthetic agents. However, more and more patients are anaesthetised using intravenously administered drugs, such as propofol, because there is growing evidence that intravenously administered drugs have several advantages over inhaled ones: shorter recovery times and less frequent adverse side effects. Compatibility with other drugs is also better, which is crucial for balanced anaesthesia. The increasing clinical use of intravenous anaesthetics is accompanied by the alarming fact that no viable instruments exist for monitoring their blood plasma concentration.

The second application, analysis of carbon 14-C/12-C isotope ratio from CO2 samples, responds to the emerging need to monitor the fossil to modern carbon ratio and to detect leakages in Carbon Capture and Storage (CCS) systems. The EU Emissions Trading Scheme, together with the proposed CCS Directive, are expected to keep the EU on track to meet its target to cut greenhouse gas emissions in Europe by 20% by 2020 compared to 1990 levels. CCS is emerging technology concept and currently there is no established state of the art, particularly with regards to monitoring of CO2 leakages in the storage strata.'

Introduzione (Teaser)

EU-funded researchers investigated ultra-sensitive optical cavity ring-down spectroscopy (CRDS) to monitor blood plasma levels during anaesthetic administration.

Descrizione progetto (Article)

Current lack of a viable technique to monitor blood plasma levels is a critical safety concern as over 100 million people undergo surgery under general anaesthesia. Scientists of the project 'Middle-infrared optical spectroscopy for anaesthetic agent and carbon isotope analysis' (MOSAIC) used the middle-infrared spectral range in CRDS to develop innovative analytical instrumentation.

For clinical application, CRDS was designed to operate at about 3 micrometre wavelength for propofol studies. For light source with mid-IR wavelengths, researchers intend to use a compact distributed feedback semiconductor laser. This set-up is currently under construction.

Project research is also applicable to monitoring fossil to modern carbon ratio and to detect leaks in carbon capture and storage (CCS) systems. MOSAIC designed a CRD spectrophotometer for operation at 4.5 micrometre wavelength for CCS applications and successfully completed construction of the first test set-up. Test results revealed that this set-up is capable of achieving desired sensitivity levels for enriched C-14 samples.

Further research on these topics is ongoing through other research collaborations despite the end of this project. Such activities should realise the development of suitable techniques for exhaled breath diagnostics and C-14 isotope measurements in the near future.

Altri progetti dello stesso programma (FP7-PEOPLE)

BET(TER) TARGETS (2013)

Targeting BET Bromodomains in Cancer – Mechanisms of Sensitivity and Resistance

Read More  

FORECOFUN-SSA (2012)

Assessing climate change impacts over large areas of primary forests in southern South America

Read More  

MULTIMODALATTENTION (2008)

Multimodal imaging of spatial attention networks in the human brain

Read More